News Releases

Select year
Categories

Myriad Genetics and Abbott Extend Collaboration

Nov 22, 2005 | Pipeline

Read more

Myriad Genetics' Follow-on Study of Flurizan™ Demonstrates Cognitive Improvement in Alzheimer's Disease

Nov 15, 2005 | Products

Read more

Myriad Genetics Announces Exercise of Over-Allotment Option by Underwriters of Public Offering

Nov 08, 2005 | Financial

Read more

Myriad Genetics Announces Pricing of Common Stock Offering

Nov 03, 2005 | Financial

Read more

Myriad Genetics Commences Offering of Common Stock

Oct 28, 2005 | Financial

Read more

Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2006

Oct 26, 2005 | Financial

Read more

Myriad Genetics Announces First Quarter Fiscal 2006 Financial Results Conference Call

Oct 19, 2005 | Financial

Read more

Myriad Genetics Publishes Depression Gene Discovery

Oct 18, 2005 | Pipeline

Read more

Myriad Genetics Advances Antithrombin Drug Development

Oct 11, 2005 | Pipeline

Read more

Myriad Genetics Discovers COB1 Gene for Early-Onset Obesity

Sep 29, 2005 | Pipeline

Read more

Myriad Genetics' Follow-on Study of Flurizan™ Demonstrates Continued Effect in Alzheimer's Disease

Sep 22, 2005 | Products

Read more

Myriad Genetics to Present at the UBS Global Life Sciences Conference on September 26, 2005

Sep 20, 2005 | Corporate

Read more

Myriad Genetics Reports Financial Results for Fiscal 2005

Aug 23, 2005 | Financial

Read more

Myriad Genetics Announces Fourth Quarter and Year End Fiscal 2005 Financial Results Conference Call

Aug 09, 2005 | Financial

Read more

Myriad Genetics Phase 3 Trial in Alzheimer's Disease is Proceeding on Schedule

Aug 02, 2005 | Pipeline

Read more

Myriad Genetics is Exclusive Licensee of New Mayo Clinic Patent on Amyloid Lowering Drugs

Jun 29, 2005 | Pipeline

Read more

Myriad Genetics Presents Results of Phase 2 Trial of Flurizan™ in Patients With Alzheimer's Disease

Jun 20, 2005 | Products

Read more

Myriad Genetics Announces Flurizan Phase 2 Results Presentation Conference Call

Jun 15, 2005 | Products

Read more

Myriad Genetics Licenses Cancer Drug Technology to Salmedix

May 24, 2005 | Products

Read more

Myriad Genetics Reports Results for Third Quarter of Fiscal 2005

May 04, 2005 | Financial

Read more

Myriad Genetics Announces Third Quarter Fiscal 2005 Financial Results Conference Call

May 02, 2005 | Financial

Read more

Myriad Genetics Reports Results of Phase 2 Trial of Flurizan™ in Patients With Alzheimer's Disease

May 02, 2005 | Products

Read more

Myriad Genetics Presents New Data on Cancer Drugs at AACR

Apr 18, 2005 | Products

Read more

Myriad Genetics Elects New Chairman John Henderson

Apr 13, 2005 | Corporate

Read more

Myriad Genetics Files Form S-3 Shelf Registration for Outstanding Shares of Common Stock

Apr 07, 2005 | Financial

Read more

Myriad Initiates Phase 1 Trial of MPC-6827 in Metastatic Brain Cancer

Mar 01, 2005 | Pipeline

Read more

Myriad Genetics Reports Results for Second Quarter of Fiscal 2005

Feb 08, 2005 | Financial

Read more

Myriad Genetics' European Breast Cancer Patents Upheld by EPO

Feb 01, 2005 | Corporate

Read more

Myriad Genetics Announces Second Quarter Fiscal 2005 Financial Results Conference Call

Jan 28, 2005 | Financial

Read more

Myriad Genetics to Present at the Piper Jaffray Healthcare Conference on January 25, 2005

Jan 20, 2005 | Corporate

Read more

Myriad Genetics Initiates Phase 3 Clinical Trial of Flurizan™ in Alzheimer's Disease

Jan 12, 2005 | Products

Read more

Myriad Genetics to Present at the 23rd Annual JPMorgan Healthcare Conference on January 12, 2005

Jan 06, 2005 | Corporate

Read more